The Diabetic Eye Disease: Mechanisms Underlying Pathophysiology and Therapies 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 13021
Special Issue Editor
Interests: cornea; nanomedicine; wound healing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In July 2019, the International Conference on Eye Diseases, sponsored by the United Scientific Group, was held in Fort Lauderdale, Florida. In this Special Issue of the International Journal of Molecular Sciences, we are pleased to present a compilation of articles representing scientific talks related to the conference topics including macular degeneration, diabetic retinopathy, glaucoma, corneal diseases, the impact of genetics, and novel approaches to treatment modalities for ocular complications. Based on these reports, the focus of this issue of the International Journal of Molecular Sciences has been put on the various aspects of diabetic eye disease including mechanisms, animal models, diagnosis and treatment. The articles reflect various aspects of eye diseases and provide insight into molecular mechanisms and therapeutic targets; interactions between genes, biochemical pathways, and genetic background; and their impacts on disease development and progression, as well as therapeutic interventions and clinical perspectives related to the disease processes. This includes both scientific research and clinical studies, which provide the basis for intellectual exchanges in understanding eye diseases.
The roles of genes involved in disrupting the retina, cornea, lens, and other parts of the eye together with compromised functions of cell organelles including the mitochondria and vascular basement membrane and cellular processes such as autophagy, ganglion cell death, occluding, and Wnt signaling in retinal angiogenesis, abnormalities of lysyl oxidase in diabetic retinopathy, and UPR signaling in bone marrow stem cells were some of the highlights of the scientific sessions at the conference. Clinical presentations focused on the importance of the genetic background, including outcomes governed by various genes and environmental factors in diabetic retinopathy, between diabetes and cornea, between endothelial progenitor cells and retinal vascular regeneration, soluble cytokine receptors in DME patients, VEGF and neuronal integrity in diabetic retinopathy. Presentations on the association of eye proteins with the cognition and management of diabetic tractional detachments received close attention as did talks on the significance of using broad-spectrum therapy for inherited retinal diseases and ocular neuromyotonia as a clinical neuro-ophthalmologic spectrum. The poster session attracted attention from all participants at the meeting. Overall, the conference was a great get-together of prominent scientists and clinicians with a common interest in improving the well-being of patients with eye disease, in particular, diabetic retinopathy.
Prof. Dr. Alexander V. Ljubimov
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- diabetic retinopathy
- cornea
- glaucoma
- diabetes therapy
- growth factor
- laser surgery
- diabetic eye disease
- molecular signaling
- diabetic macular edema
- neovascularization
- tractional detachment
- drugs
- nanomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
